linked by a carbon chain containing aromatic rings

Industry

CPC
C07D419/10

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07DHETEROCYCLIC COMPOUNDS C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms

Current Industry

C07D419/10linked by a carbon chain containing aromatic rings

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compound for organic electric element, organic electric element usi...
- Patent number 11,950,502
- Issue date Apr 2, 2024
- DUK SAN NEOLUX CO., LTD.
- Hyoung Keun Park
- C09 - DYES PAINTS POLISHES NATURAL RESINS ADHESIVES MISCELLANEOUS COMPOSITION...
Information Patent Grant
Inhibitors of KEAP1-Nrf2 protein-protein interaction
- Patent number 11,897,900
- Issue date Feb 13, 2024
- JANSSEN PHARMACEUTICA NV
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KEAP1-Nrf2 protein-protein interaction
- Patent number 11,427,601
- Issue date Aug 30, 2022
- JANSSEN PHARMACEUTICA NV
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound for organic electronic element, organic electronic element...
- Patent number 10,998,502
- Issue date May 4, 2021
- DUK SAN NEOLUX CO., LTD.
- Hyoung Keun Park
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Grant
Inhibitors of KEAP1-Nrf2 protein-protein interaction
- Patent number 10,947,252
- Issue date Mar 16, 2021
- JANSSEN PHARMACEUTICA NV
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nrf2 regulators
- Patent number 10,144,731
- Issue date Dec 4, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Thomas Glanmor Davies
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fungicidal amides
- Patent number 9,730,447
- Issue date Aug 15, 2017
- E I du Pont de Nemours and Company
- James Francis Bereznak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted phenyl-oxathiazine derivatives, method for producing th...
- Patent number 8,895,547
- Issue date Nov 25, 2014
- Sanofi
- Thomas Boehme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oxathiazine derivatives which are substituted with benzyl or hetero...
- Patent number 8,846,666
- Issue date Sep 30, 2014
- Sanofi
- Thomas Boehme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted phenyl-oxathiazine derivatives, method for producing th...
- Patent number 8,809,324
- Issue date Aug 19, 2014
- Sanofi
- Thomas Boehme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitors
- Patent number 8,618,153
- Issue date Dec 31, 2013
- Bristol-Myers Squibb Company
- John A. Bender
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and their use as angiotensin antagonists
- Patent number 6,100,252
- Issue date Aug 8, 2000
- Takeda Chemical Industries, Ltd.
- Takehiko Naka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds and their use as angiotensin antagonists
- Patent number 5,883,111
- Issue date Mar 16, 1999
- Takeda Chemical Industries, Ltd.
- Takehiko Naka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds and their use as angiotensin antagonists
- Patent number 5,736,555
- Issue date Apr 7, 1998
- Takeda Chemical Industries, Ltd.
- Takehiko Naka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds and their use as angiotensin antagonists
- Patent number 5,583,141
- Issue date Dec 10, 1996
- Takeda Chemical Industries, Ltd.
- Takehiko Naka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 1,2,4-triazolin-3-one compounds bearing acidic function...
- Patent number 5,436,259
- Issue date Jul 25, 1995
- Merck & Co., Inc.
- Wallace T. Ashton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound and salts thereof which antagonize angiotensin II
- Patent number 5,354,766
- Issue date Oct 11, 1994
- Takeda Chemical Industries, Ltd.
- Takehiko Naka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 1,2,4-triazoles bearing acidic functional groups as ang...
- Patent number 5,281,614
- Issue date Jan 25, 1994
- Merck & Co., Inc.
- Wallace T. Ashton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound which is angiotensin II antagonist
- Patent number 5,243,054
- Issue date Sep 7, 1993
- Takeda Chemical Industries, Ltd.
- Takehiko Naka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 1-(2H)-isoquinolinones bearing acidic functional groups...
- Patent number 5,162,340
- Issue date Nov 10, 1992
- Merck & Co., Inc.
- Prasun K. Chakravarty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides
- Patent number 4,675,044
- Issue date Jun 23, 1987
- Uniroyal Chemical Company, Inc.
- Walter G. Brouwer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-Aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides
- Patent number 4,569,690
- Issue date Feb 11, 1986
- Uniroyal, Inc.
- Walter G. Brouwer
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NRF2-ACTIVATING COMPOUND
- Publication number 20240132519
- Publication date Apr 25, 2024
- SENJU PHARMACEUTICAL CO., LTD.
- Tomoyo MIYABE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
- Publication number 20240109884
- Publication date Apr 4, 2024
- LG CHEM, LTD.
- Minjun KIM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL4I1 INHIBITORS AND METHODS OF USE
- Publication number 20230183214
- Publication date Jun 15, 2023
- Merck Sharp & Dohme LLC
- Brandon D. CASH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2-ACTIVATING COMPOUND
- Publication number 20230024995
- Publication date Jan 26, 2023
- SENJU PHARMACEUTICAL CO., LTD.
- Tomoyo MIYABE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION
- Publication number 20220315604
- Publication date Oct 6, 2022
- Janssen Pharmaceutica N.V.
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USI...
- Publication number 20210242408
- Publication date Aug 5, 2021
- DUK SAN NEOLUX CO., LTD.
- Hyoung Keun PARK
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Application
INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION
- Publication number 20200055874
- Publication date Feb 20, 2020
- Janssen Pharmaceutica N.V.
- J. Kent Barbay
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2 Regulators
- Publication number 20190002454
- Publication date Jan 3, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Jeffrey Charles BOEHM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NRF2 REGULATORS
- Publication number 20160318917
- Publication date Nov 3, 2016
- GlaxoSmithKline Intellectual Property Development Limited
- Jeffrey Charles Boehm
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETERO...
- Publication number 20140066437
- Publication date Mar 6, 2014
- SANOFI
- Thomas Boehme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20140018389
- Publication date Jan 16, 2014
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUC...
- Publication number 20130345127
- Publication date Dec 26, 2013
- SANOFI
- Thomas Boehme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUC...
- Publication number 20130338066
- Publication date Dec 19, 2013
- SANOFI
- Thomas Boehme
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20130012540
- Publication date Jan 10, 2013
- Bristol -Myers Squibb Company
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hepatitis C Virus Inhibitors
- Publication number 20110281910
- Publication date Nov 17, 2011
- Bristol -Myers Squibb Company
- Rico Lavoie
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GAMMA SECRETASE MODULATORS
- Publication number 20110257163
- Publication date Oct 20, 2011
- Schering Corporation
- Anandan Palani
- C07 - ORGANIC CHEMISTRY

linked by a carbon chain containing aromatic rings

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Compound for organic electric element, organic electric element usi...

Inhibitors of KEAP1-Nrf2 protein-protein interaction

Inhibitors of KEAP1-Nrf2 protein-protein interaction

Compound for organic electronic element, organic electronic element...

Inhibitors of KEAP1-Nrf2 protein-protein interaction

Nrf2 regulators

Fungicidal amides

Substituted phenyl-oxathiazine derivatives, method for producing th...

Oxathiazine derivatives which are substituted with benzyl or hetero...

Substituted phenyl-oxathiazine derivatives, method for producing th...

Hepatitis C virus inhibitors

Heterocyclic compounds and their use as angiotensin antagonists

Heterocyclic compounds and their use as angiotensin antagonists

Heterocyclic compounds and their use as angiotensin antagonists

Heterocyclic compounds and their use as angiotensin antagonists

Substituted 1,2,4-triazolin-3-one compounds bearing acidic function...

Compound and salts thereof which antagonize angiotensin II

Substituted 1,2,4-triazoles bearing acidic functional groups as ang...

Compound which is angiotensin II antagonist

Substituted 1-(2H)-isoquinolinones bearing acidic functional groups...

3-aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides

3-Aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides

Patents Applicationslast 30 patents

NRF2-ACTIVATING COMPOUND

NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

IL4I1 INHIBITORS AND METHODS OF USE

NRF2-ACTIVATING COMPOUND

INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION

COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USI...

INHIBITORS OF KEAP1-Nrf2 PROTEIN-PROTEIN INTERACTION

NRF2 Regulators

NRF2 REGULATORS

OXATHIAZINE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL OR HETERO...

Hepatitis C Virus Inhibitors

NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUC...

NOVEL SUBSTITUTED PHENYL-OXATHIAZINE DERIVATIVES, METHOD FOR PRODUC...

Hepatitis C Virus Inhibitors

Hepatitis C Virus Inhibitors

GAMMA SECRETASE MODULATORS